Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05652673 |
| Title | Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial |
| Recruitment | Recruiting |
| Gender | both |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | Erasmus Medical Center |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NLD |